Skip to content

Longitudinal Study of Outcomes Measures in ALS Trials

Longitudinal Study Comparing the Responsiveness of Outcomes Measures in ALS Trials

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01911130
Enrollment
100
Registered
2013-07-30
Start date
2013-07-31
Completion date
2016-03-31
Last updated
2017-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amyotrophic Lateral Sclerosis

Keywords

outcomes measures, strength measurement, disease progression

Brief summary

A new strength measurement device called Accurate Test of Limb Isometric Strength (ATLIS) was developed to precisely and conveniently measure static limb strength in patients with ALS. The investigators will compare ATLIS data with data from two commonly used ALS outcomes measures, the ALS Functional Rating Scale-Revised (ALSFRS-R) and slow vital capacity (SVC) in a prospective, longitudinal study. All three outcomes measures will be performed on 100 subjects collected preferably at bi-monthly clinic visits during the study period.

Detailed description

Four sites will participate in data collection for this study and will enroll approximately 20-30 subjects per site. Subjects will be tested every 1 to 4 months for up to two years. Subjects will be tested at each visit using ATLIS, ALSFRS-R questionnaire and slow vital capacity testing. Inclusion criteria: * Subjects 18 years or older diagnosed with clinically possible, laboratory supported probable, probable or clinically definite ALS according to the World Federation of Neurology Revised El Escorial Criteria. * Capable of providing informed consent and complying with trial procedures. Exclusion criteria: \- Patients, judged by the site clinical investigator to have medical conditions that may limit their ability to safely exert maximal force using the muscles in their arms and legs will be excluded from this study (e.g. unstable hypertension, significant cardiac disease, significant musculoskeletal disorders, or other medical conditions).

Interventions

None listed

Sponsors

ALS Association
CollaboratorOTHER
Massachusetts General Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* 18 years or older * clinically possible, laboartory supported probable, probable or clinically definite ALS according to El Escorial Criteria * capable of providing informed consent

Exclusion criteria

* persons with medical conditions that would limit their ability to safely exert maximal force using muscles in their arms and legs (e.g. unstable cardiac, musculoskeletal, or other medical conditions)

Design outcomes

Primary

MeasureTime frameDescription
Change in Accurate Test of Limb Isometric Strength (ATLIS) between each visitevery 1 to 4 months for up to two yearsATLIS measures isometric strength in 12 muscle groups in the arms and legs. The subject is tested seated in a specially designed chairs with adjustable uprights. The subject's limb is placed in a standard position and maximal force is exerted on the wireless load cell fixed to the upright. Strength data is digitally captured and expressed as a percentage of expected normal.

Secondary

MeasureTime frameDescription
Change in ALS Functional Rating Scale - Revised (ALSFRS-R) between each visitevery 1 to 4 months for up to 2 yearsThis questionnaire consists of 12 questions about the subject's ability to function in certain daily activities. Questions are asked in an interview format.
Change in Slow Vital Capacity (SVC) between each visitEvery 1 to 4 months for up to two yearsSVC measures the amount of air you can exhale following a deep breath. For this test, we will ask you to hold a mouthpiece in your mouth, breathe in deeply, and breathe out as much air as you can, up to 5 times.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026